scholarly journals Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: a multicenter retrospective study

2017 ◽  
Vol 8 (5) ◽  
pp. 737-743 ◽  
Author(s):  
Jia-yu Zhu ◽  
Cheng-cheng Liu ◽  
Liang Wang ◽  
Mei Zhong ◽  
Hai-lin Tang ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Retrospective Study ◽  
Prognostic Factor ◽  
Epithelial Ovarian Cancer ◽  
Peripheral Blood Lymphocyte ◽  
Peripheral Blood ◽  
Blood Lymphocyte ◽  
Lymphocyte To Monocyte Ratio ◽  
Advanced Epithelial Ovarian Cancer

Prognostic factor in advanced epithelial ovarian cancer (EOC) analysis of a cooperative group experience

1986 ◽  
Vol 23 (2) ◽  
pp. 259 ◽  
Author(s):  
S. Pecorelli ◽  
S. Marsoni ◽  
P. Sanpaolo ◽  
F. Giardina ◽  
L. Vassena ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Prognostic Factor ◽  
Epithelial Ovarian Cancer ◽  
Cooperative Group ◽  
Advanced Epithelial Ovarian Cancer ◽  
Group Experience

Bowel involvement in advanced epithelial ovarian cancer as a prognostic factor

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 16536-16536
Author(s):  
M. L. Arora ◽  
S. Saha ◽  
S. J. Sirop ◽  
S. Manyam ◽  
D. Iddings ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Prognostic Factor ◽  
Epithelial Ovarian Cancer ◽  
Bowel Involvement ◽  
Advanced Epithelial Ovarian Cancer

scholarly journals The Predictive Value of the Peripheral Blood Lymphocyte-to-Monocyte Ratio in Patients with Anaplastic Large Cell Lymphoma

2021 ◽  
Author(s):  
Shengnan Zhang ◽  
Yuqing Chen ◽  
Qian Wang ◽  
Fangfang Yuan ◽  
Hao Ai ◽  
...  
Keyword(s):  
Peripheral Blood Lymphocyte ◽  
Anaplastic Large Cell Lymphoma ◽  
Peripheral Blood ◽  
Blood Lymphocyte ◽  
Cell Lymphoma ◽  
Characteristic Curve ◽  
Large Cell ◽  
High Baseline ◽  
Lymphocyte To Monocyte Ratio ◽  
Large Cell Lymphoma

Abstract BackgroundTo assess the value of the peripheral blood lymphocyte-to-monocyte ratio (LMR) in predicting the early treatment response and prognosis in patients with anaplastic large cell lymphoma (ALCL).MethodsThe optimal cut-off value for the LMR was determined using the receiver operating characteristic curve (ROC) method. The LMR was monitored dynamically, and the relationship between the LMR and therapeutic response, and survival was analyzed.Results The cumulative complete remission (CCR) rate was 57.1% in patients with low baseline LMR, remarkably lower than that for patients with high baseline LMR (80.0%) (P = 0.019). The 5-year overall survival (OS) and progression-free survival (PFS) were 51.3% and 32.6%, respectively, in the low baseline LMR group, which were significantly poorer at 90.4% and 70.5% in the high baseline LMR group, respectively (P values were 0.006 and 0.013, respectively). Furthermore, the median OS and PFS of patients with a decreased LMR after treatment were shorter than those with an elevated LMR after treatment (all P values < 0.05). Univariate and multivariate analysis demonstrated that low baseline LMR is an independent indicator for poor prognosis in ALCL patients (P values were 0.006 and 0.020, respectively). Interestingly, the combination of low baseline LMR and ALK positive could strongly predict the good prognosis in patients with ALCL. ConclusionsThe low baseline LMR and a decreased LMR after treatment are prognostic indicator for poor PFS and OS. The combination of LMR and ALK expression can widely risk-stratify patients for treatment and survival in patients with ALCL.

Sign in / Sign up

Export Citation Format

Share Document